Search
Quince Therapeutics Inc
QNCXAdd to Watchlist
33.000USD
-1.040-3.06%
Close 08-14 16:00（ET）Quotes delayed by 15 min
22.75MMarket Cap
1.46P/E TTM
Forecast
Currency: USD Updated:Analyst Rating
Based on
7
analysts
Buy
Current Rating
82.750
Target Price
+143.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Quince Therapeutics Inc
QNCX
7
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Quince Therapeutics Inc's price target?
Analysts forecast that Quince Therapeutics Inc's price target is USD 8.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 4.00.
How have Quince Therapeutics IncQNCX's recent earnings per share performed?
The market expectation was USD -12.31, while Quince Therapeutics IncQNCX's earnings per share (EPS) for the previous quarter was USD 78.75. EPS for the next quarter is expected at USD -1.41.
What is the analyst rating for Quince Therapeutics Inc?
Based on the ratings of Quince Therapeutics Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.